Hibah Shaath | Hamad Bin Khalifa University

Dr. Hibah Shaath

Senior Research Associate

Dr. Hibah Shaath

Senior Research Associate

Educational Qualifications

PhD Biomedical and Biological Sciences

MRes Genetic Medicine

Entity

Qatar Biomedical Research Institute

Divison

Translational Oncology Research Center

Biography

Dr. Hibah Shaath obtained her Bachelor of Science (Hons) and Master of Research (MRes) degrees in Genetics and Genetic Medicine from the University of Manchester. The focus of her MRes was the biomolecular characterization of Keratoconic corneas associated with transplant rejection. In 2013 she moved to Qatar and joined Shafallah Medical Genetics Center, where her main focus was identifying candidate genes with novel mutations associated with both Mendelian hereditary disease and ASD, through homozygosity mapping and family screening, presented in several posters at ARC’13 and ARC’14. In 2014, Dr. Shaath joined QBRI to work as a Research Associate in the Translational Oncology Research Center. In 2022, she completed her PhD in Biomedical and Biological Sciences from the College of Health and Life Sciences (CHLS) at HBKU under the supervision of Dr. Nehad Alajez. Her research focus is on the transcriptional landscape of colorectal cancer and breast cancer for novel biomarker discovery and targeted therapy. Her research was selected for oral presentation at the first Advances in Precision Medicine (APM 2021) conference at HBKU, and in 2022; her poster was selected for Best Poster Award in the student category as the third place winner at HBKU Research Day.

 

PhD Biomedical and Biological Sciences

College of Health and Life Sciences

September 2017 - June 2022

MRes Genetic Medicine

The University of Manchester

September 2011 - September 2012

BSc (Honors) Genetics

The University of Manchester

September 2007 - June 2010

Research Associate

Qatar Biomedical Research Institute (QBRI) - Doha, Qatar

June 2014 - Present

Research Associate

Shafallah Medical Genetics Center- Doha, Qatar

January 2013 - June 2014

  • HBKU Research Day: Best Poster Award, Student Category; third place winner for poster on Therapeutic targeting for Colorectal Cancer: Toward Precision Medicine
  • Abstract chosen for oral presentation at the first Advances in Precision Medicine (APM 2021) conference at HBKU: Single-cell long noncoding RNA (lncRNA) transcriptome implicates MALAT1 in triple-negative breast cancer (TNBC) resistance to neoadjuvant chemotherapy